Stock SAVA CASSAVA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cassava Sciences, Inc.

Equities

SAVA

US14817C1071

Real-time Estimate Cboe BZX
Other stock markets
 19:08:19 23/05/2024 BST 		5-day change 1st Jan Change
21.74 USD -1.72% Intraday chart for Cassava Sciences, Inc. +1.62% -2.67%
05-17 HC Wainwright Adjusts Price Target on Cassava Sciences to $131 From $124, Maintains Buy Rating MT
05-10 Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CASSAVA SCIENCES, INC. Stock Cassava Sciences, Inc.
 1.06B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. SAVA Stock
  4. Charts Cassava Sciences, Inc.
  5. Sector Chart